
Preclinical Research Sets the Stage for Potential of CAR-NK Cell Therapy in Hematologic Malignancies
However, researchers also noted that similar to chimeric antigen receptor (CAR) T-cell therapy, CAR-NK cell treatment comes with its own set of challenges.
































